Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.
暂无分享,去创建一个
H. Deeg | K. Sullivan | R. Storb | F. Appelbaum | C. Anasetti | P. Weiden | R. Witherspoon | J. Sanders | K. Doney | F. Appelbaum | S. Dahlberg | Weiden Pl
[1] Jean E. Sanders,et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. , 1988, Blood.
[2] E. Thomas,et al. Marrow transplantation for malignant disease. , 1987, The American journal of the medical sciences.
[3] R. Greenlee,et al. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. , 1987, The New England journal of medicine.
[4] E. Friedman,et al. Alternate-day cyclosporine. Allograft and antibody immunosuppression. , 1987, Transplantation.
[5] S. Thiru,et al. Alternate-day cyclosporine A and azathioprine in experimental dog renal allografts. , 1987, Transplantation proceedings.
[6] L. Lum. The kinetics of immune reconstitution after human marrow transplantation. , 1987, Blood.
[7] E. Friedman,et al. Daily and alternate-day cyclosporine immunosuppressive regimens and synergism with azathioprine. , 1987, Transplantation proceedings.
[8] H. Deeg,et al. Age‐dependent cyclosporine: Pharmacokinetics in marrow transplant recipients , 1986, Clinical pharmacology and therapeutics.
[9] M. Sacchetti,et al. Cell-mediated suppression of megakaryocytopoiesis in acquired amegakaryocytic thrombocytopenic purpura. , 1986, Blood.
[10] R. Parkman. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones. , 1986, Journal of immunology.
[11] K. Sullivan,et al. Second marrow infusion for poor graft function after allogeneic marrow transplantation. , 1986, Bone marrow transplantation.
[12] H. Deeg,et al. Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. , 1986, Blood.
[13] H. Deeg,et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.
[14] H. Heimpel,et al. CYCLOSPORINE AS AN ALTERNATIVE TO CYCLOPHOSPHAMIDE IN THE TREATMENT OF CHRONIC GRAFT‐VERSUS‐HOST DISEASE , 1986, Transplantation.
[15] K. Sullivan,et al. Intestinal and hepatic complications of human bone marrow transplantation. Part I. , 1986, Gastroenterology.
[16] R. Storb,et al. Marrow transplantation from related donors other than HLA-identical siblings. , 1985, The New England journal of medicine.
[17] H. Deeg,et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts , 1985 .
[18] H. Deeg,et al. Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine. , 1985, The American journal of medicine.
[19] Kennedy,et al. Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. , 1985, Blood.
[20] H. Deeg,et al. Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft‐versus‐host disease prophylaxis , 1985, British journal of haematology.
[21] J. Lipton,et al. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. , 1985, Blood.
[22] R. Storb,et al. PHARMACOKINETICS OF INTRAVENOUS CYCLOSPORINE IN BONE MARROW TRANSPLANT PATIENTS: COMPARISON OF TWO ASSAY METHODS , 1984, Transplantation.
[23] B. Myers,et al. Cyclosporine-associated chronic nephropathy. , 1984, The New England journal of medicine.
[24] K. Sullivan,et al. Oral manifestations of chronic graft-v-host disease. , 1984, Archives of internal medicine.
[25] A. Hess,et al. Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants. , 1983, Blood.
[26] K. Sullivan,et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. , 1982, Blood.
[27] A. Fauci,et al. Corticosteroid‐Mediated Immunoregulation in Man , 1982, Immunological reviews.
[28] K. Sullivan,et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment , 1981 .
[29] K. Sullivan,et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. , 1981, The New England journal of medicine.
[30] K. Sullivan,et al. Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. , 1981, Transplantation proceedings.
[31] K. Sullivan,et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. , 1981, Blood.
[32] A. Barrett,et al. CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MAN , 1978, The Lancet.
[33] Clift,et al. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. , 1976, Blood.
[34] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.
[35] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[36] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[37] K. Sullivan,et al. Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation. , 1987, Progress in clinical and biological research.
[38] P. Colombani,et al. Cyclosporine and the immune response: basic aspects. , 1986, Critical reviews in immunology.
[39] K. Sullivan,et al. Intestinal and hepatic complications of human bone marrow transplantation. Part II. , 1986, Gastroenterology.
[40] K. Sullivan. Acute and chronic graft-versus-host disease in man. , 1986, International journal of cell cloning.
[41] H. Deeg,et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. , 1985, Blood.
[42] H. Deeg,et al. Late complications after marrow transplantation. , 1984, Seminars in hematology.
[43] H. Ochs,et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. , 1981, Blood.